Laminil™ is available in Canada and most of the United States.

• Laminil™ Cream (120 gram per jar, transdermal base)

• Laminil™ Solution (sterile solution 60mL/10% cromolyn sodium per vial)

Willowcroft Pharm Announces U.S. Availability of Laminil Treatment for Laminitis

January 23, 2017

Laminil, a new anti-inflammatory treatment that STOPS laminitis, is now available by veterinary prescription. 

• Laminitis is an inflammatory response. Laminil halts the inflammatory process.
• Laminil is an injectable solution for treating acute and chronic laminitis and is administered by upper regional limb perfusion.
• The efficacy and safety of Laminil have been demonstrated in clinical tests and field studies involving over 275 horses around the world. Over 60% of horses fully recovered in 14 days, and no toxic side effects were reported.
• The active pharmaceutical ingredient in Laminil is Cromolyn (sodium cromoglycate), which is an FDA-approved human drug that is described in the pharmacology literature as “virtually nontoxic” because it is not metabolized.
• Laminil will help you save horses from laminitis.
• Laminil is also available in Transdermal Cream.

Veterinarians can register, prescribe, and order Laminil Perfusion and Transdermal for clients and their horses by clicking “How to Prescribe and Purchase Laminil” on the home page.

Telephone: 303-875-7402                  

Email: info@willowcroftpharm.com